Can a drug help severely obese kids lose weight?
NCT ID NCT02273804
First seen Jan 04, 2026 · Last updated May 01, 2026 · Updated 17 times
Summary
This study tested the drug topiramate in 18 severely obese children and teens aged 9 to 17. The goal was to see if it could lower their Body Mass Index (BMI) more than a placebo over 9 months. Success was defined as a BMI reduction greater than 2.5%. The study also tracked side effects and other weight-related changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESE CHILDREN AND ADOLESCENTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hopital Bicêtre
Le Kremlin-Bicêtre, Paris, 94275, France
Conditions
Explore the condition pages connected to this study.